Trials / Completed
CompletedNCT01115933
A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population
SPIRIT PRIME JAPAN (SV JAPAN)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the AVJ-09-385 Small Vessel Everolimus Eluting Coronary Stent System (EECSS) (2.25 mm diameter stent) in treatment of subjects with ischemic heart disease caused by de novo lesions.
Conditions
- Vascular Disease
- Myocardial Ischemia
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | XIENCE PRIME SV EECSS | Patients receiving XIENCE PRIME SV EECSS |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Completion
- 2013-12-01
- First posted
- 2010-05-04
- Last updated
- 2015-08-13
- Results posted
- 2014-01-03
Locations
14 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01115933. Inclusion in this directory is not an endorsement.